ELUVOGUE Trademark

Trademark Overview

On Thursday, April 12, 2018, a trademark application was filed for ELUVOGUE with the United States Patent and Trademark Office. The USPTO has given the ELUVOGUE trademark a serial number of 87874399. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 1, 2021. This trademark is owned by AbbVie Biotechnology Ltd. The ELUVOGUE trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
eluvogue

General Information

Serial Number87874399
Word MarkELUVOGUE
Filing DateThursday, April 12, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 1, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 31, 2018

Trademark Statements

Goods and Servicespharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, April 20, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAbbVie Biotechnology Ltd
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressHamilton HM11
BM
Party NameAbbVie Biotechnology Ltd
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHamilton HM11
BM

Trademark Events

Event DateEvent Description
Monday, November 1, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, November 1, 2021ABANDONMENT - NO USE STATEMENT FILED
Saturday, March 20, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 19, 2021EXTENSION 5 GRANTED
Monday, March 8, 2021EXTENSION 5 FILED
Friday, March 19, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, March 8, 2021TEAS EXTENSION RECEIVED
Friday, September 18, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 16, 2020EXTENSION 4 GRANTED
Wednesday, September 16, 2020EXTENSION 4 FILED
Wednesday, September 16, 2020TEAS EXTENSION RECEIVED
Tuesday, March 17, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 13, 2020EXTENSION 3 GRANTED
Friday, March 13, 2020EXTENSION 3 FILED
Friday, March 13, 2020TEAS EXTENSION RECEIVED
Tuesday, September 24, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 20, 2019EXTENSION 2 GRANTED
Friday, September 20, 2019EXTENSION 2 FILED
Friday, September 20, 2019TEAS EXTENSION RECEIVED
Thursday, March 7, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 5, 2019EXTENSION 1 GRANTED
Tuesday, March 5, 2019EXTENSION 1 FILED
Tuesday, March 5, 2019TEAS EXTENSION RECEIVED
Tuesday, September 25, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 31, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 31, 2018PUBLISHED FOR OPPOSITION
Wednesday, July 11, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 26, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 26, 2018ASSIGNED TO EXAMINER
Friday, April 20, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, April 16, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

eluvogue gastrointestinal hormonal neurological respiratory ophthalmic dermatological psychiatric diseases disorders related